Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes

Area of Science:

• Cardiology
• Molecular Biology
• Pharmacology

Background:

• 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) offer cholesterol-independent benefits, potentially via nitric oxide.
• The direct effects of statins on cardiac myocytes and their mitochondrial targets remain under investigation.

Purpose of the Study:

• To investigate whether simvastatin directly protects cardiac myocytes from oxidant stress.
• To determine if mitochondria are targets for simvastatin's cardioprotective effects in myocytes.

Main Methods:

• Neonatal rat cardiac myocytes were cultured and exposed to hydrogen peroxide (H2O2) induced oxidant stress.
• Mitochondrial membrane potential was assessed using flow cytometry with tetramethylrhodamine ethyl ester (TMRE).
• Effects of simvastatin were evaluated in the presence of nitric oxide synthase inhibitor (L-NAME) and mitochondrial potassium channel blocker (5-hydroxydecanoate).

Main Results:

• Hydrogen peroxide significantly reduced mitochondrial membrane potential in cardiac myocytes.
• Simvastatin pre-treatment significantly attenuated this H2O2-induced mitochondrial depolarization.
• The protective effect of simvastatin was blocked by L-NAME and 5-hydroxydecanoate, indicating roles for nitric oxide and mitoKATP channels.

Conclusions:

• Simvastatin directly protects cardiac myocytes against oxidant stress by preserving mitochondrial membrane potential.
• Myocytes can initiate cardioprotective responses to simvastatin, involving nitric oxide and mitochondrial potassium channels.
• These findings support statin therapy as a potential strategy for pharmacological preconditioning.